Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Weight Gain Management in Patients With Schizophrenia During Treatment With Olanzapine in Association With Nizatidine

NCT00486005 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT00486005
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00486005 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Weight Gain Management in Patients With Schizophrenia During Treatment With Olanzapine in Association With Nizatidine
Lead sponsor
Eli Lilly and Company
Phase
Phase 4
Overall status
Completed
Start date
February 28, 2003
Completion date
October 31, 2003
Enrollment
74 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia